Skip to main content
Yelena Janjigian, MD, Oncology, New York, NY, Memorial Sloan-Kettering Cancer Center

YelenaYJanjigianMD

Oncology New York, NY

Instructor, Medicine, Weill Cornell Medical College

Overview of Dr. Janjigian

Dr. Yelena Janjigian is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. She received her medical degree from NYU Grossman School of Medicine and has been in practice 14 years. Dr. Janjigian accepts several types of health insurance, listed below. She is one of 418 doctors at Memorial Sloan-Kettering Cancer Center who specialize in Oncology.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2003 - 2006
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2019 - 2023
  • NY State Medical License
    NY State Medical License 2006 - 2023
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies  
    Sam S Yoon, Yelena Janjigian, Daniel G Coit, Zsofia K Stadler, Vivian E Strong, JAMA Surgery
  • YES1 Amplification Is a Mechanism of Acquired Resistance to EGFR Inhibitors Identified by Transposon Mutagenesis and Clinical Genomics  
    Emmet J Jordan, Helena A Yu, Yelena Y Janjigian, Mark G Kris, Paul K Paik, Jamie E Chaft, Lu Wang, Gregory J Riely, Proceedings of the National Academy of Sciences

Lectures

  • Biomarkers to Guide Surveillance and Adjuvant Therapy of Early-Stage Disease 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • Biomarkers for Better Treatment and Patient Selection 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • Checkpoint Blockade in Esophagogastric Cancer 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Authored Content

  • Combination Therapies: The Wave of the FutureJanuary 2019
  • Checkpoint Blockade in Esophagogastric CancerJune 2018

Press Mentions

  • Novel Approaches Explored in HER2-Positive Gastric Cancer
    Novel Approaches Explored in HER2-Positive Gastric CancerJanuary 18th, 2016
  • Janjigian Highlights Lessons Learned from 2020 Gastrointestinal Cancers Symposium
    Janjigian Highlights Lessons Learned from 2020 Gastrointestinal Cancers SymposiumFebruary 14th, 2020
  • Imugene : Appoints Dr. Yelena Janjigian as a Scientific Advisory Board Member
    Imugene : Appoints Dr. Yelena Janjigian as a Scientific Advisory Board MemberApril 12th, 2016
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment